Here are the Form 4 insider transactions from Lifevantage Corporation (LFVN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow LFVN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LFVN filings page.
Lifevantage Corp director Michael A. Beindorff received 17,888 common shares on November 5, 2026, under the outside director compensation program. The award vests in one installment on November 5, 2027, subject to his continuous service through that date. His direct holdings after the award were 45,458 shares; reported indirect holdings included 41,625 shares held by the Michael A. Beindorff Trust U/A DTD 06/14/2000, 126 held by his spouse as custodian for minor children, and 5,500 held by his spouse. The reported $5.87 per-share figure is the weighted average closing price for the ten trading days ending the day before the grant.
Lifevantage Corp director Rajendran Anbalagan acquired 17,888 common shares on November 5, 2026, under the issuer’s outside director compensation program. The award will vest in a single installment on November 5, 2027, subject to his continuous service through that date. The reported $5.87 per-share figure equals the weighted average closing price over the ten trading days ending the day before the grant; it is not described as a purchase price. He directly held 41,887 common shares following the grant.
Lifevantage Corp director Darwin Lewis received a grant of 17,888 common shares on November 5, 2026, under the company’s outside director compensation program. The shares will vest in a single installment on November 5, 2027, subject to his continuous service through that date. The reported $5.87 per share is the weighted average closing price for the ten trading days ending the day before the grant. Lewis reported direct holdings of 156,132 shares following the grant.
Lifevantage Corp (LFVN) director Raymond B. Greer received an award of 17,888 common shares on November 5, 2026. His reported direct holdings after the award were 130,707 shares. The award was made under the issuer’s outside director compensation program and is scheduled to vest in one installment on November 5, 2027, subject to his continuous service through that date. The reported $5.87 per-share figure equals the weighted average closing price for the ten trading days ending the day before the grant.
Lifevantage Corp director Judd Dayton received an award of 17,888 common shares on November 5, 2026, under the outside director compensation program. The reported $5.87 per share is the weighted average closing price for the 10 trading days ending the day before the grant. The shares vest in a single installment on November 5, 2027, subject to continuous service. His reported direct holdings following the award were 98,247 shares; a separate indirect holding of 749,325 shares is listed as held by Sudbury Capital Fund, LP.
Lifevantage Corp (LFVN) Chief Sales Officer Kristen Cunningham acquired 32,850 stock units, each a right to one common share, and 49,275 performance restricted stock units on October 7, 2026. Her reported direct common-stock holdings after the stock-unit award were 152,375 shares. The stock units vest in three equal installments on October 7, 2027, October 7, 2028 and October 7, 2029, subject to continued service. The PRSUs vest only to the extent financial performance targets are achieved over a three-and-a-half-year period from October 2026 through March 2030 and subject to continued service; at maximum performance, Cunningham may become eligible to earn 150% of the target number of units.
Lifevantage Corp (LFVN) Chief Financial Officer Carl Aure reported awards on October 7, 2026, covering 35,749 stock units and 53,623 performance restricted stock units (PRSUs), each representing a right to receive common stock. The stock units vest in thirds subject to continued service; the PRSUs vest only to the extent financial performance targets are achieved over a three-and-a-half-year period ending in March 2030, subject to continued service. At maximum performance, Aure may become eligible to earn 150% of the PRSU target. The common-stock row reports 191,784 shares following the transaction.
Lifevantage Corp (LFVN) reported grant awards to President and CEO Terrence Moorehead on October 7, 2026: a 193,237-unit stock award and 289,855 performance restricted stock units (PRSUs). The transaction rows report 501,879 directly held common shares following the stock award and 289,855 PRSUs following the PRSU award.
Each stock unit represents a right to receive one common share and vests in thirds on October 7, 2027, October 7, 2028, and October 7, 2029, subject to continued service. PRSUs vest only to the extent performance targets are achieved and continued-service conditions are met; at maximum performance, Moorehead may become eligible to earn 150% of the target units.
Lifevantage Corp (LFVN) Chief Financial Officer Carl Aure reported that 460 shares of common stock were delivered or withheld on October 1, 2026, for payment of exercise price or tax liability. The reported price was $6.24 per share. Aure held 156,035 shares directly after the transaction.
Lifevantage Corp (LFVN) Chief Sales Officer Kristen Cunningham reported 637 shares of common stock delivered or withheld for payment of exercise price or tax liability on October 1, 2026. The reported price was $6.24 per share. The transaction was classified as a direct disposition, and Cunningham directly held 119,525 shares of common stock following the transaction.
Lifevantage Corp (LFVN) reports that director Lewis Darwin purchased common stock in the company. On September 15, 2026, he bought 976 shares at $6.22 per share in an open-market or private transaction, increasing his directly held stake to 138,244 shares. The filing affirms that this trade was made under a Rule 10b5-1 trading plan.
Lifevantage Corp (LFVN) reported that its Chief Financial Officer, Carl Aure, had 1,869 shares of common stock withheld or delivered on September 10, 2026 to pay the exercise price or related tax liability at a reported price of $6.37 per share. After this transaction, he held 156,495 shares directly, which include 2,810 shares purchased on August 31, 2026 under the Employee Stock Purchase Plan. No Rule 10b5-1 trading plan is reported for this transaction.
Lifevantage Corp (LFVN) reported that Chief Sales Officer Kristen Cunningham executed several transactions in the company’s common stock. On September 14, 2026, she sold 8,901 shares at a weighted average price of $6.18 per share, with individual trade prices ranging from $6.15 to $6.26. She also sold 100 shares at $6.41 on September 11, 2026, and on September 10, 2026, 2,254 shares were delivered or withheld for payment of exercise price or tax liability at $6.37 per share. No Rule 10b5-1 trading plan is reported for these transactions.
Moorehead Terrence reported acquisition or exercise transactions in this Form 4 filing.
Lifevantage Corp granted President and CEO Terrence Moorehead equity awards on August 6, 2026. He received 308,642 shares of common stock as a stock unit award that vests in three equal installments on August 6 of 2027, 2028, and 2029, subject to continued service. He was also granted 540,123 Performance Restricted Stock Units (PRSUs), each representing one share of common stock. These PRSUs vest only if specified financial performance targets are achieved over a three-year period from August 6, 2026 to August 6, 2029, with 10% vesting at each achievement date and an additional 10% vesting on the first anniversary of each such achievement date, contingent on continued service.
Lifevantage Corp Chief Financial Officer Aure Carl reported a tax-related share disposition on Common Stock. A total of 1,361 shares were used to satisfy tax obligations at a reference price of $6.25 per share. After this tax-withholding disposition, Carl directly holds 155,554 shares of Lifevantage common stock.
Lifevantage Corp Chief Sales Officer Kristen Cunningham reported a tax-withholding disposition of company stock tied to equity compensation. On the reported date, 1,717 shares of common stock were withheld at a price of $6.25 per share to cover tax obligations. After this transaction, she directly holds 131,417 shares of Lifevantage common stock, so her overall ownership remains substantial and the event appears routine and compensation-related rather than an open-market trade.
Lifevantage Corp General Counsel Alissa Neufeld reported a routine tax-related share disposition. On July 1, 2026, 1,342 shares of common stock were delivered at $6.25 per share to satisfy tax obligations, classified as a tax-withholding disposition rather than an open-market trade. Following this transaction, Neufeld directly holds 112,744 shares of Lifevantage common stock.
Lifevantage Corp director Darwin Lewis reported an open-market purchase of company stock. On this Form 4, he bought 705 shares of Common Stock at a price of $8.595 per share. Following this transaction, he directly owns 137,268 shares of Lifevantage Corp Common Stock.
Lifevantage Corp director Michael A. Beindorff reported an indirect open-market sale of 10,000 shares of common stock on June 3, 2026. The sale, executed by the Michael A. Beindorff Trust, had a weighted average price of $8.5459 per share, with trades ranging from $8.00 to $8.94.
Following the sale, the trust held 41,625 shares. The filing also shows additional indirect holdings of 5,500 shares held by his spouse and 126 shares held by his spouse as custodian for minor children, plus 27,570 shares held directly by Beindorff.
Lifevantage Corp General Counsel Alissa Neufeld reported a routine share withholding related to taxes. On April 1, 2026, 1,446 shares of Common Stock were disposed of at $4.20 per share as a tax-withholding disposition, not an open‑market sale. Following this transaction, she directly owns 114,086 shares of Lifevantage Common Stock.
Lifevantage Corp President and CEO Steven R. Fife reported a tax-related share disposition involving company common stock. On April 1, 2026, 8,180 shares were delivered at $4.20 per share to cover exercise price or tax obligations.
This transaction is classified as a tax-withholding disposition, not an open-market sale. After the adjustment, Fife directly holds 735,471 shares of Lifevantage common stock, indicating he retains a significant equity stake in the company following this routine administrative event.
Lifevantage Corp Chief Financial Officer Aure Carl reported a routine tax-related share transfer. On April 1, 2026, he disposed of 1,527 shares of common stock at an indicated value of $4.20 per share to cover tax obligations by delivering shares.
After this tax-withholding disposition, Carl directly holds 156,915 shares of Lifevantage common stock. Because the transaction was for tax payment rather than an open-market sale, it reflects compensation-related administration rather than an active decision to buy or sell shares in the market.
Lifevantage Corp chief sales officer Kristen Cunningham reported a small share disposition related to tax withholding. On a compensation-related transaction, 1,928 shares of common stock were withheld at $4.20 per share to cover tax obligations.
After this event, she continues to directly hold 133,134 shares of Lifevantage common stock.
Lifevantage Corp director Lewis Darwin reported an open-market purchase of common stock. On this transaction date, he bought 1,055 shares at $5.23 per share, increasing his direct holdings to 136,563 shares. This filing shows a modest increase in his personal investment in the company.
Lifevantage Corp director Dayton Judd reported open-market purchases of the company’s common stock. He bought 10,500 shares on March 2, 2026 at $4.53, 18,097 shares on February 27, 2026 at $4.63, and 4,600 shares on February 26, 2026 at $4.58, totaling 33,197 shares.
After these transactions, Judd directly owns 80,359 shares. The filing also shows 749,325 shares held indirectly through Sudbury Capital Fund, LP, an investment entity with which he is associated.
LifeVantage director Darwin Lewis bought 3,955 shares of company common stock in an open‑market transaction at a weighted average price of $5.2216 per share. After this purchase on February 9, 2026, he directly owns 135,508 LifeVantage shares.
Lifevantage Corp director Michael Beindorff reported gifting company stock to a family trust. On 11/25/2025, he transferred 7,819 shares of Lifevantage common stock in a transaction coded "G," which indicates a gift with a reported price of $0 per share.
After this transaction, he directly owned 27,570 shares and indirectly held 51,625 shares through the Michael A. Beindorff Trust, where he and his spouse are trustees. Additional indirect holdings include 126 shares held by his spouse as custodian for minor children and 5,500 shares held by his spouse.
LifeVantage Corp (LFVN) director Michael A. Beindorff reported a sale of company stock in a Form 4 filing. On 11/19/2025, a trust for which he and his spouse serve as trustees sold 12,607 shares of LifeVantage common stock at a weighted average price of $6.4198 per share, with individual trades executed between $6.39 and $6.48. After this transaction, he reported beneficial ownership of 43,806 shares held by the trust, 35,389 shares held directly, 126 shares held by his spouse as custodian for minor children, and 5,500 shares held by his spouse.